US2003003117A1PendingUtilityA1

Hydrolyzed whole egg products & related methods

Priority: Jun 18, 2001Filed: Jan 8, 2002Published: Jan 2, 2003
Est. expiryJun 18, 2021(expired)· nominal 20-yr term from priority
A61K 8/64A61K 8/9789A61K 8/982A61K 8/46A61K 8/986A61K 47/10A61K 9/0014A61K 47/44A61Q 19/00A61Q 19/06A61K 38/012A61K 8/345A61K 8/9794A61K 47/46
37
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a formulation comprising hydrolyzed whole egg, an emollient substance and a humectant substance; and provides a method of incorporating a hydrolyzed whole egg into a cosmetic, pharmaceutical and medicinal formulation wherein the hydrolyzed whole egg acts as a nutrient source and as a carrier of the active ingredients in the formulation to desired bodily targets.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A formulation comprising at least one hydrolyzed whole egg, at least one emollient substance and at least one humectant substance.  
     
     
         2 . The formulation of  claim 1  wherein said humectant substance is selected from a group consisting of glycerin, butylenes glycol, propylene glycol, pentylene glycol and mixtures thereof.  
     
     
         3 . The formulation of  claim 1  wherein said emollient substance is selected from a group consisting of Prunus Amygdalus Dulis (Sweet Almond) Oil, Squalene, Prunus Armeniaca (Apricot) Kernel Oil, Carthamus Tinetorius (Safflower) Oil, Helianthus Annuus (Sunflower) Seed Oil, synthetic oils and extracts thereof and mixtures thereof.  
     
     
         4 . The formulation of  claim 1  wherein said formulation is a cosmetic formulation.  
     
     
         5 . The formulation of  claim 1  wherein said formulation is a cosmopharmaceutical formulation.  
     
     
         6 . The formulation of  claim 1  wherein said formulation is a pharmaceutical formulation.  
     
     
         7 . A cellulite formulation comprising at least one hydrolyzed whole egg, at least one emollient substance, at least one humectant substance and at least one aromatherapeutical substance.  
     
     
         8 . The formulation of  claim 7  wherein said humectant substance is selected from a group consisting of glycerin, butylenes glycol, propylene glycol, pentylene glycol and mixtures thereof.  
     
     
         9 . The formulation of  claim 7  wherein said emollient substance is selected from a group consisting of Prunus Amygdalus Dulis (Sweet Almond) Oil, Squalene, Prunus Armeniaca (Apricot) Kernel Oil, Carthamus Tinetorius (Safflower) Oil, Helianthus Annuus (Sunflower) Seed Oil and extracts thereof and mixtures thereof.  
     
     
         10 . The formulation of  claim 7  wherein said aromatherapeutical substance is selected from a group consisting of Lavendula Angustifolia (Lavender) oil, Geranium Maculatum Oil, Citrus Grandis (Grapefruit) oil, Juniperus Communis Oil, Pimenta Acris (Bay) Oil, Lavendula Hybrida, Geranium Robertianum, Geranium Thunbergil, Citrus Aurantium Dulsis (Orange) Oil, Citrus Nobilis (Mandarin Orange) Oil, Citrus Limonum (Lemon) Oil and extracts thereof and mixtures thereof.  
     
     
         11 . A skin care formulation comprising at least one hydrolyzed whole egg, at least one emollient substance, at least one humectant substance and at least one skin nourishing/wound healing substance.  
     
     
         12 . The formulation of  claim 11  wherein said humectant substance is selected from a group consisting of glycerin, butylenes glycol, propylene glycol, pentylene glycol and mixtures thereof.  
     
     
         13 . The formulation of  claim 11  wherein said emollient substance is selected from a group consisting of Prunus Amygdalus Dulis (Sweet Almond) Oil, Squalene, Prunus Armeniaca (Apricot) Kernel Oil, Carthamus Tinetorius (Safflower) Oil, Helianthus Annuus (Sunflower) Seed Oil and extracts thereof and mixtures thereof.  
     
     
         14 . The formulation of  claim 11  wherein said skin nourishing/wound healing substance is selected from a group consisting of aloe barbadensis leaf juice, white willow bark, and extracts thereof and mixtures thereof.  
     
     
         15 . The formulation of  claim 11  further comprising an acne drug and said formulation functions as an acne formulation.  
     
     
         16 . The formulation of  claim 15  wherein said active drug is salicylic acid.  
     
     
         17 . A muscle soothing formulation comprising at least one hydrolyzed whole egg, at least one emollient substance, at least one humectant substance and a muscle soothing substance.  
     
     
         18 . The formulation of  claim 17  wherein said humectant substance is selected from a group consisting of glycerin, butylenes glycol, propylene glycol, pentylene glycol and mixtures thereof.  
     
     
         19 . The formulation of  claim 17  said emollient substance is selected from a group consisting of Prunus Amygdalus Dulis (Sweet Almond) Oil, Squalene, Prunus Armeniaca (Apricot) Kernel Oil, Carthamus Tinetorius (Safflower) Oil, Helianthus Annuus (Sunflower) Seed Oil and extracts thereof and mixtures thereof.  
     
     
         20 . The formulation of  claim 17  wherein said muscle soothing substance comprises a blend of Menthol, Methyl Salicylate, Eucalyptus Globulus Oil, Camphor, and Mentha Piperita (Peppermint) Oil.  
     
     
         21 . A hydrolyzed whole egg formulation manufactured by a method comprising: 
 shearing a mixture of water, triethanolamine, glycerin and methyl paraben and heating said mixture to a temperature from about 70 degrees Celsius to about 80 degrees Celsius;    adding sweet almond oil, stearic acid, glyceryl stearate, and propylparaben to said mixture and shearing and heating the entire mixture to a temperature from about 90 degrees Celsius to about 100 degrees Celsius;    adding a hydrolyzed egg to the oil phase of the entire mixture while stopping the heating process and adding the oil phase to the water phase to form an emulsion; and    upon formation of the emulsion, cooling the entire formulation.    
     
     
         22 . The formulation of  claim 21  further comprising adding additional substances to said formulation during said cooling process.  
     
     
         23 . The formulation of  claim 21  wherein said formulation is a cosmetic formulation.  
     
     
         24 . The formulation of  claim 21  wherein said formulation is a cosmopharmaceutical formulation.  
     
     
         25 . The formulation of  claim 21  wherein said formulation is a pharmaceutical formulation.  
     
     
         26 . A skin care formulation manufactured by a process comprising: 
 shearing a mixture of water, triethanolamine, trisodium EDTA, glycerin and methyl paraben and heating said mixture to a temperature from about 70 degrees Celsius to about 80 degrees Celsius;    adding cetearyl alcohol, sweet almond oil, cetyl alcohol, stearic acid, glyceryl stearate, sorbitan stearate, tocopherol, retinyl palmitate, tetrahexyldecyl ascorbate and propylparaben to said mixture and shearing and heating the entire mixture to a temperature from about 90 degrees Celsius to about 100 degrees Celsius;    adding a hydrolyzed egg to the oil phase of the entire mixture while stopping the heating process and adding the oil phase to the water phase to form an emulsion;    upon formation of the emulsion, cooling the entire formulation; and    adding glycerin, salicylic acid and phenoxyethyanol and shearing the entire formulation.    
     
     
         27 . The formulation of  claim 26  wherein said formulation is used for acne skin care.  
     
     
         28 . A muscle soothing formulation manufactured by a process comprising: 
 shearing a mixture of water, triethanolamine, glycerin, trisodium and methyl paraben and heating said mixture to a temperature from about 70 degrees Celsius to about 80 degrees Celsius;    adding sweet almond oil, cetearyl alcohol, stearic acid, glyceryl stearate, cetyl lactate, tocopherol, retiryl palmitate, tetrahexyldecyl ascorbate and propylparaben to said mixture and shearing and heating the entire mixture to a temperature from about 90 degrees Celsius to about 100 degrees Celsius;    adding a hydrolyzed egg to the oil phase of the entire mixture while stopping the heating process and adding the oil phase to the water phase to form an emulsion;    upon formation of the emulsion, cooling the entire formulation; and    adding cyclomethicone, menthol, methyl salicylate, eucalyptus globules oil, camphor, peppermint oil, pheroxyethanol and chlorophyll and shearing the entire formulation.    
     
     
         29 . A cellulite formulation manufactured by a process comprising: 
 shearing a mixture of water, triethanolamine, glycerin, propylene glycol and methyl paraben and heating said mixture to a temperature from about 70 degrees Celsius to about 80 degrees Celsius;    adding sweet almond oil, cetyl lactate, stearic acid, paraffin, sorbitan stearate, glyceryl stearate, cyclomethicone and dimethicone copotyol, and propylparaben to said mixture and shearing and heating the entire mixture to a temperature from about 90 degrees Celsius to about 100 degrees Celsius;    adding a hydrolyzed egg to the oil phase of the entire mixture while stopping the heating process and adding the oil phase to the water phase to form an emulsion;    upon formation of the emulsion, cooling the entire formulation; and    adding grapefruit oil, lavender oil, geranium maculatum oil, juniperus communis oil, cumen extract, sambucus nigra extract, caraway extract, sage extract, parsley extract, primula veris extract and phenoxyethanol and shearing the entire formulation.    
     
     
         30 . A method of manufacturing a formulation, said method comprising: 
 shearing at least one emollient substance and at least one humectant substance;    adding at least one hydrolyzed whole egg to the oil phase of the mixture and then adding the oil phase to the water phase to form an emulsion; and    upon formation of the emulsion, cooling said formulation.    
     
     
         31 . The method of  claim 30  wherein said humectant substance is selected from a group consisting of glycerin, butylenes glycol, propylene glycol, pentylene glycol and mixtures thereof.  
     
     
         32 . The method of  claim 30  wherein said emollient substance is selected from a group consisting of Prunus Amygdalus Dulis (Sweet Almond) Oil, Squalene, Prunus Armeniaca (Apricot) Kernel Oil, Carthamus Tinetorius (Safflower) Oil, Helianthus Annuus (Sunflower) Seed Oil and extracts thereof and mixtures thereof.  
     
     
         33 . The method of  claim 30  wherein said formulation is a cosmetic formulation.  
     
     
         34 . The method of  claim 30  wherein said formulation is a cosmopharmaceutical formulation.  
     
     
         35 . The method of  claim 30  wherein said formulation is a pharmaceutical formulation.

Join the waitlist — get patent alerts

Track US2003003117A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.